Nuche, J, Ternacle, J, Avvedimento, M, Cheema, AN, Veiga-Fernández, G, Muñoz-García, AJ, Vilalta, V, Regueiro, A, Asmarats, L, del Trigo, M, Serra, V, Bonnet, G, Jonveaux, M, Esposito, G, Rezaei, E, de la Torre-Hernández, JM, Fernández-Nofrerías, E, Vidal, P, Gutiérrez-Alonso, L, Oteo, JF, Belahnech, Y, Mohammadi, S, Philippon, F, Modine, T, Mesnier, J, Rodés-Cabau, J. Incidence, predictors, and prognostic significance of impaired functional status early after transcatheter aortic valve replacement. REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(5)DOI:10.1016/j.rec.2023.11.003. PMID:38000627. IF:4.900(Q1/2D).

Escate, R, Padró, T, de Isla, LP, Fuentes, F, Alonso, R, Mata, P, Badimon, L. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients. ATHEROSCLEROSIS. 2024; 392DOI:10.1016/j.atherosclerosis.2024.117502. PMID:38513437. IF:5.700(Q1/1D).

Ballester-Servera, C, Alonso, J, Cañes, L, Vázquez-Sufuentes, P, García-Redondo, AB, Rodríguez, C, Martínez-González, J. Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress. Antioxidants. 2024; 13(5)DOI:10.3390/antiox13050523. PMID:38790628. IF:6.600(Q1/1D).

Gomez-Peralta, F, Ballesteros, AC, Martínez, AM, Corral, BP, Donlo, IC, Melo, PF, Arnáez, FZ, Rodríguez, MM. Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities-based post hoc analysis of the OneCare study. DIABETES OBESITY & METABOLISM. 2024; 26(5)DOI:10.1111/dom.15496. PMID:38379106. IF:5.700(Q1/2D).

Beato-Vibora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Gimenez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mira, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting Response. DIABETES CARE. 2024; 47(5)DOI:10.2337/dci24-0017. PMID:38640410. IF:16.600(Q1/1D).

Garcia, MJ, Riestra, S, Amiot, A, Julsgaard, M, de la Filia, IG, Calafat, M, Aguas, M, de la Pena, L, Roig, C, Caballol, B, Casanova, MJ, Farkas, K, Boysen, T, Bujanda, L, Cuaran, C, Dobru, D, Fousekis, F, Gargallo-Puyuelo, CJ, Savarino, E, Calvet, X, Huguet, JM, Kupcinskas, L, López-Cardona, J, Raine, T, van Oostrom, J, Gisbert, JP, Chaparro, M. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 59(10)DOI:10.1111/apt.17938. PMID:38445785. IF:6.700(Q1/1D).

Gómez-Labrador, C, Ricart, E, Iborra, M, Iglesias, E, Martín-Arranz, MD, de Castro, L, De Francisco, R, García-Alonso, FJ, Sanahuja, A, Gargallo-Puyuelo, CJ, Mesonero, F, Casanova, MJ, Mañosa, M, Rivero, M, Calvo, M, Sierra-Ausin, M, González-Muñoza, C, Calvet, X, García-López, S, Guardiola, J, García, LA, Márquez-Mosquera, L, Gutiérrez, A, Zabana, Y, Navarro-Llavat, M, Poyatos, RL, Piqueras, M, Torrealba, L, Bermejo, F, Ponferrada-Díaz, A, Pérez-Calle, JL, Barreiro-de Acosta, M, Tejido, C, Cabriada, JL, Marín-Jiménez, I, Roncero, O, Ber, Y, Fernández-Salazar, L, Aler, BC, Lucendo, AJ, Llaó, J, Bujanda, L, Villafranca, CM, Domènech, E, Chaparro, M, Gisbert, JP. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics. 2024; 16(5)DOI:10.3390/pharmaceutics16050629. PMID:38794292. IF:5.500(Q1/1D).

Menajovsky, MF, Espunyes, J, Ulloa, G, Calderon, M, Diestra, A, Malaga, E, Muñoz, C, Montero, S, Lescano, AG, Santolalla, ML, Cabezón, O, Mayor, P. Toxoplasma gondii in a Remote Subsistence Hunting-Based Indigenous Community of the Peruvian Amazon. Tropical Medicine and Infectious Disease. 2024; 9(5)DOI:10.3390/tropicalmed9050098. PMID:38787031. IF:2.600(Q1/1D).